17q21基因型影响产前维生素D预防儿童哮喘与反复喘息的效果
该研究对两项产前维生素D补充预防子代哮喘的随机对照试验(VDAART与COPSAC2010)进行二次分析,按rs12936231基因型分层并整合代谢物数据。结果显示,维生素D对哮喘/喘息的保护作用仅见于低风险GG基因型儿童(HR 0.49,95%CI 0.26-0.94,p=0.032),而在高风险CC基因型中未见保护(HR 1.08,95%CI 0.69-1.69,p=0.751)。机制上,GG基因型中维生素D补充与血浆鞘脂类(包括S1P)升高相关,且鞘脂水平与哮喘/喘息风险降低相关。
要点
- 产前维生素D对儿童哮喘/喘息的保护作用受17q21 rs12936231基因型影响,仅GG基因型获益。
- GG基因型中维生素D补充与鞘脂类(含S1P)升高相关,CC基因型中未见此关联。
- 鞘脂水平与哮喘/喘息风险降低相关,且维生素D、基因型与S1P存在交互作用(p=0.035)。
核心结论
- 产前维生素D补充可能通过依赖17q21基因型的鞘脂代谢改变降低早期儿童哮喘/喘息风险。
研究设计与样本
- 对VDAART和COPSAC2010两项产前维生素D补充预防子代哮喘的随机对照试验进行合并二次分析,按基因型分层并整合代谢物数据。
主要发现
- 维生素D对哮喘/喘息的保护作用见于低风险rs12936231 GG基因型儿童(HR 0.49,95%CI 0.26-0.94,p=0.032),高风险CC基因型未见保护(HR 1.08,95%CI 0.69-1.69,p=0.751)。
- 在VDAART中,GG基因型儿童维生素D补充与血浆鞘脂类升高相关,包括鞘氨醇-1-磷酸(β 0.022,95%CI 0.001-0.044,p=0.038),CC基因型中未观察到此关联。
- 鞘脂水平与哮喘/喘息风险降低相关,且维生素D、基因型与鞘氨醇-1-磷酸存在交互作用(p-interaction=0.035)。
- 细胞模型中,过表达ORMDL3的支气管上皮细胞系与对照细胞系在维生素D诱导鞘氨醇-1-磷酸生成方面存在显著差异(p=0.002)。
临床怎么用
- 产前维生素D补充预防儿童哮喘/喘息的效果可能因17q21基因型而异,GG基因型儿童更可能获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Evidence suggests vitamin D has preventive potential in asthma; however, not all children benefit from this intervention. This study aimed to investigate whether variation in the functional 17q21 single nucleotide polymorphism rs12936231 affects the preventive potential of vitamin D against asthma.A combined secondary analysis of two randomised controlled trials of prenatal vitamin D supplementation for the prevention of asthma in offspring (Vitamin D Antenatal Asthma Reduction Trial (VDAART) and Copenhagen Prospective Studies on Asthma in Childhood 2010 (COPSAC2010)) was performed, stratifying by genotype and integrating metabolite data to explore underlying mechanisms.The protective effect of vitamin D on asthma/wheeze was evident among children with the low-risk rs12936231 GG genotype (hazard ratio (HR) 0.49, 95% CI 0.26-0.94, p=0.032) but not the high-risk CC genotype (HR 1.08, 95% CI 0.69-1.69, p=0.751). In VDAART, in the GG genotype vitamin D supplementation was associated with increased plasma levels of sphingolipids, including sphingosine-1-phosphate (β 0.022, 95% CI 0.001-0.044, p=0.038), but this was not evident with the CC genotype, known to be associated with increased expression of ORMDL3 in bronchial epithelial cells. Sphingolipid levels were associated with decreased risk of asthma/wheeze, and there was evidence of interactions between sphingolipid levels, vitamin D and genotype (p-interactionvitaminD*genotype*sphingosine-1-phosphate=0.035). In a cellular model, there was a significant difference in the induction of sphingosine-1-phosphate by vitamin D between a control human bronchial epithelial cell line and a cell line overexpressing ORMDL3 (p=0.002).Results suggest prenatal vitamin D supplementation may reduce the risk of early childhood asthma/wheeze via alterations of sphingolipid metabolism dependent on the 17q21 genotype.
引用
- Kelly RS, Chawes BL, Guo F, et al. The role of the 17q21 genotype in the prevention of early childhood asthma and recurrent wheeze by vitamin D. Eur Respir J. 2019. PMID: 31439681. doi:10.1183/13993003.00761-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。